Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMS1EQ7)

Drug Name

PF-1228305 Drug Info

Synonyms

Sitaxentan sodium; Sitaxsentan sodium

Indication

Disease Entry	ICD 11	Status	REF
Pulmonary hypertension	BB01	Phase 3	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Approved Drug(s)

Clinical Trial Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Endothelin A receptor (EDNRA)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Bosentan	DMIOGBU	Pulmonary arterial hypertension	BB01.0	Approved	[2]
Ambrisentan	DMD1QXW	Pulmonary arterial hypertension	BB01.0	Approved	[3]
Macitentan	DMP79A1	Cardiovascular disease	BA00-BE2Z	Approved	[4]
Sparsentan	DMMP51W	IgA nephropathy	MF8Y	Approved	[5]
LU302146	DMMJVXZ	Pulmonary hypertension	BB01	Approved	[6]
Atrasentan	DMM74PK	Diabetic nephropathy	GB61.Z	Phase 3	[7]
Clazosentan	DMQSBX4	Cerebral vasospasm	BA85.Z	Phase 3	[8]
Darusentan	DMN8DQH	Hypotension	BA20-BA21	Phase 3	[9]
BQ-123	DM0MO8I	Pulmonary arterial hypertension	BB01.0	Phase 2	[10]
FR139317	DMEL5SV	Hypertension	BA00-BA04	Phase 2	[11]
------------------------------------------------------------------------------------


⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

References

1	Pfizer. Product Development Pipeline. March 31 2009.
2	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.
3	Clinical pipeline report, company report or official report of GlaxoSmithKline (2009).
4	Radium 223 dichloride for prostate cancer treatment. Drug Des Devel Ther. 2017 Sep 6;11:2643-2651.
5	Designed multiple ligands. An emerging drug discovery paradigm. J Med Chem. 2005 Oct 20;48(21):6523-43.
6	Influence of endothelin receptor antagonists on myocardial protein kinase C isoforms in uraemic cardiomyopathy. Clin Sci (Lond). 2002 Aug;103 Suppl 48:276S-279S.
7	Effects of a selective ET(A)-receptor antagonist, atrasentan (ABT-627), in murine models of allergic asthma: demonstration of mouse strain specificity. Clin Sci (Lond). 2002 Aug;103 Suppl 48:367S-370S.
8	Effects of the selective endothelin A (ET(A)) receptor antagonist Clazosentan on cerebral perfusion and cerebral oxygenation following severe subar... Acta Neurochir (Wien). 2007;149(9):911-8; discussion 918.
9	Endothelin ETA receptor blockade with darusentan increases sodium and potassium excretion in aging rats. J Cardiovasc Pharmacol. 2006 Mar;47(3):456-62.
10	Endothelin in heart failure: a promising therapeutic target Heart. 1997 Feb;77(2):93-4.
11	Reduction of bFGF-induced smooth muscle cell proliferation and endothelin receptor mRNA expression by mevastatin and atorvastatin. Biochem Pharmacol. 2002 Aug 1;64(3):497-505.